Meta-analysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug-eluting stents

Journal of Endovascular Therapy

Volumn 20, Issue 2, 2013, Pages 131-144

  Antoniou, George A ^a   Chalmers, Nicholas ^a   Kanesalingham, Kavitha ^a   Antoniou, Stavros A ^b   Schiro, Andrew ^a   Serracino Inglott, Ferdinand ^a   Smyth, John Vincent ^a   Murray, David ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Angioplasty; Balloon expandable stents; Drug eluting stents; In stent restenosis; Infragenicular arteries; Infrapopliteal arteries; Limb ischemia; Meta analysis; Occlusion; Patency; Stenosis; Systematic review; Target lesion revascularization; Tibial arteries

Indexed keywords

EVEROLIMUS; RAPAMYCIN;

ARTICLE; BARE METAL STENT; CLAUDICATION; DRUG ELUTING STENT; EFFECT SIZE; FREEDOM; HOSPITALIZATION; HUMAN; INFRAPOPLITEAL OCCLUSIVE DISEASE; LEG ISCHEMIA; LIMB SALVAGE; META ANALYSIS; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; STUDY DESIGN; SYSTEMATIC REVIEW;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CHI-SQUARE DISTRIBUTION; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; HUMANS; ISCHEMIA; LIMB SALVAGE; LOWER EXTREMITY; ODDS RATIO; POPLITEAL ARTERY; PROSTHESIS DESIGN; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84877788360     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/1545-1550-20.2.131     Document Type: Article

References (45)

1. Santilli JD, Santilli SM. Chronic critical limb ischemia: diagnosis, treatment and prognosis. Am Fam Physician. 1999;59:1899-1908. (Pubitemid 29169723)
2. Burns P, Gough S, Bradbury AW. Management of peripheral arterial disease in primary care. BMJ. 2003;326(7389):584-588. (Pubitemid 36337587)
3. American College of Cardiology Foundation; American Heart Association Task Force; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine; Society for Vascular Surgery, Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). Vasc Med. 2011;16:452-476.
4. Norgren L, Hiatt WR, Dormandy JA, et al; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S: S5-67.
5. Bernstein O, Chalmers N. New treatments for infrapopliteal disease: devices, techniques, and outcomes so far. Cardiovasc Intervent Radiol. 2012;35:715-724.
6. Rana MA, Gloviczki P. Endovascular interventions for infrapopliteal arterial disease: an update. Semin Vasc Surg. 2012;25:29-34.
7. Söder HK, Manninen HI, Jaakkola P, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol. 2000;11:1021-1031.
8. Romiti M, Albers M, Brochado-Neto FC, et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47:975-981.
9. Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, et al. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther. 2009;16:251-260.
10. Karnabatidis D, Spiliopoulos S, Katsanos K, et al. Below-the-knee drug-eluting stents and drug-coated balloons. Expert Rev Med Devices. 2012;9:85-94.
11. Rastan A, Noory E, Zeller T. Drug-eluting stents for treatment of focal infrapopliteal lesions. Vasa. 2012;41:90-95.
12. Bosiers M, Deloose K, Callaert J, et al. Drug-eluting stents below the knee. J Cardiovasc Surg (Torino). 2011;52:231-234.
13. Katsanos K, Diamantopoulos A, Siablis D. Prime time for infrapopliteal drug-eluting stents? J Endovasc Ther. 2012;19:20-22.
14. Rosales OR, Mathewkutty S, Gnaim C. Drug eluting stents for below the knee lesions in patients with critical limb ischemia: long-term follow-up. Catheter Cardiovasc Interv. 2008;72:112-115. (Pubitemid 352008995)
15. Siablis D, Karnabatidis D, Katsanos K, et al. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results. J Vasc Interv Radiol. 2007;18:1351-1361. (Pubitemid 350010920)
16. Grant AG, White CJ, Collins TJ, et al. Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheter Cardiovasc Interv. 2008;71:108-111. (Pubitemid 351158354)
17. Balzer JO, Zeller T, Rastan A, et al. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents. J Cardiovasc Surg (Torino). 2010;51:183-191.
18. Feiring AJ, Krahn M, Nelson L, et al. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol. 2010;55:1580-1589.
19. Rastan A, Schwarzwälder U, Noory E, et al. Primary use of sirolimus-eluting stents in the infrapopliteal arteries. J Endovasc Ther. 2010;17:480-487.
20. Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv. 2006;68:793-788.
21. Werner M, Schmidt A, Freyer M, et al. Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: long-term clinical and angiographic follow-up. J Endovasc Ther. 2012;19:12-19.
22. Lookstein R, Ward T, Kim E, et al. Value of drugeluting stents after failed percutaneous transluminal angioplasty in the infrapopliteal vessels for the treatment of critical limb ischemia: favorable mid-term patency and limb salvage results. J Cardiovasc Surg (Torino). 2011;52:461-466.
23. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
24. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517-538. (Pubitemid 27408567)
25. Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg. 2012;55:390-398.
26. Rastan A, Tepe G, Krankenberg H, et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J. 2011;32:2274-2281.
27. Tepe G, Schmehl J, Heller S, et al. Drug eluting stents versus PTA with GP IIb/IIIa blockade below the knee in patients with current ulcers-The BELOW Study. J Cardiovasc Surg (Torino). 2010;51:203-212.
28. Falkowski A, Poncyljusz W, Wilk G. The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries. Eur Radiol. 2009;19:966-974.
29. Scheinert D, Ulrich M, Scheinert S, et al. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention. 2006;2:169-174.
30. Siablis D, Karnabatidis D, Katsanos K, et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol. 2009;20:1141-1150.
31. Higgins JP, Altman DG, Gtzsche PC, et al Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
32. Higgins JP, Altman DG, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1. Chapter 8: Assessing risk of bias in included studies. London: John Wiley & Sons, Ltd; 2008. Available at: http://hiv.cochrane.org/sites/hiv.cochrane.org/files/uploads/Ch08-Bias.pdf; last accessed October 2012.
33. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp; last accessed July 2012.
34. Higgins JP, Altman DG, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2. London: John Wiley & Sons, Ltd; 2009. Available at: http://www.cochrane-handbook.org; last accessed July 2012.
35. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
36. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188. (Pubitemid 17189972)
37. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560. (Pubitemid 37088507)
38. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634. (Pubitemid 27387172)
39. Sauguet A, Leger P. Tools & techniques: Below the knee interventions. EuroIntervention. 2012;7:1120-1123.
40. Donas KP, Torsello G, Schwindt A, et al. Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up. J Vasc Surg. 2010;52:356-361.
41. Schwarzwalder U, Zeller T. Below-the-knee revascularization. Advanced techniques. J Cardiovasc Surg (Torino). 2009;50:627-634.
42. Wallace EL, Abdel-Latif A, Charnigo R, et al. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction. Am J Cardiol. 2012;109:932-940.
43. Serruys PW, Ong AT, Piek JJ, et al. A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention. 2005;1:58-65.
44. Katsanos K, Karnabatidis D, Diamantopoulos A, et al. Cost-effectiveness analysis of infrapopliteal drug-eluting stents. Cardiovasc Intervent Radiol. 2013;36:90-97.
45. Antoniou GA, Sfyroeras GS, Karathanos C, et al. Hybrid endovascular and open treatment of severe multilevel lower extremity arterial disease. Eur J Vasc Endovasc Surg. 2009;38:616-622.